Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

 A number of energetic vaccination approaches have confirmed ineffective in lowering the substantial morbidity and mortality attributable to respiratory syncytial virus (RSV) in infants and older adults (aged ≥65 years). A vaccine conferring a considerable and sustainable enhance in neutralising exercise is required to guard towards extreme RSV illness. To that finish, we evaluated the security and immunogenicity of DS-Cav1, a prefusion F subunit vaccine. On this part 1 research, DS-Cav1 vaccination was secure and effectively tolerated. DS-Cav1 vaccination elicited a strong enhance in RSV F-specific antibodies and neutralising exercise that was sustained above baseline for no less than 44 weeks.

On this randomised, open-label, part 1 scientific trial, the stabilised prefusion F vaccine DS-Cav1 was evaluated for dose, security, tolerability, and immunogenicity in wholesome adults aged 18-50 years at a single US web site. Individuals had been assigned to obtain escalating doses of both 50 μg, 150 μg, or 500 μg DS-Cav1 at weeks Zero and 12, and had been randomly allotted in a 1:1 ratio inside every dose group to obtain the vaccine with or with out aluminium hydroxide (AlOH) adjuvant. A single low-dose of pre-F immunisation of antigen-experienced people may confer safety that extends all through a complete RSV season.

After 71 individuals had been randomised, the protocol was amended to permit some individuals to obtain a single vaccination at week 0. The first goals evaluated the security and tolerability at each dose inside 28 days following every injection. Neutralising exercise and RSV F-binding antibodies had been evaluated from week Zero to week 44 as secondary and exploratory goals. Security was assessed in all individuals who acquired no less than one vaccine dose; secondary and exploratory immunogenicity evaluation included all individuals with out there knowledge at a given go to.

European knowledge sources for computing burden of (potential) vaccine-preventable illnesses in ageing adults

To information decision-making on immunisation programmes for ageing adults in Europe, one of many goals of the Vaccines and InfecTious illnesses within the Ageing popuLation (IMI2-VITAL) venture is to evaluate the burden of illness (BoD) of (doubtlessly) vaccine-preventable illnesses ((P)VPD). We aimed to establish the out there knowledge sources to calculate the BoD of (P)VPD in taking part VITAL international locations and to pinpoint knowledge gaps. Primarily based on epidemiological standards and vaccine availability, we prioritized (P) VPD attributable to Further-intestinal pathogenic Escherichia coli (ExPEC), norovirus, respiratory syncytial virus, Staphylococcus aureus, and pneumococcal pneumonia.

Morbidity and mortality knowledge had been typically out there for all 5 illnesses, whereas abstract BoD estimates had been largely missing. Out there knowledge weren’t all the time stratified by age and danger group, which is very necessary when calculating BoD for ageing adults. AMR knowledge had been out there in a number of international locations for S. aureus and ExPEC. This research offers an exhaustive overview of the out there knowledge sources and knowledge gaps for the estimation of BoD of 5 (P) VPD in ageing adults within the EU/EAA, which is helpful to information pathogen-specific BoD research and contribute to calculation of (P)VPDs BoD.

Respiratory syncytial virus (RSV) is a typical pathogen inflicting extreme respiratory sickness in infants and elder adults. The event of an efficient RSV vaccine is a crucial unmet medical want and an space of energetic analysis. The normal methodology for testing neutralizing antibodies towards RSV in scientific trials is the plaque discount neutralization take a look at (PRNT), which makes use of 24-well plates and wishes six days publish an infection to develop viral plaques.

On this research, we’ve got developed a virus discount neutralization take a look at (VRNT), which permits the variety of RSV contaminated cells to be routinely counted by an imaging cytometer at someday publish an infection in 96-well plates. VRNT was discovered sturdy to cell seeding density, detection antibody focus, virus enter and an infection time.

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

Balancing Precision vs. Cohort Transcriptomic Evaluation of Acute and Restoration Part of Viral Bronchiolitis

Viral infections affecting the decrease respiratory tract place monumental burdens on hospitals. As neither vaccines nor anti-viral brokers exist for a lot of viruses, understanding danger elements and outcomes in every affected person utilizing minimally invasive evaluation, similar to blood, can result in improved healthcare supply. A cohort of PAXGene RNAseq of infants admitted with reasonable or extreme acute bronchiolitis and respiratory syncytial virus (RSV) had been in contrast with case-control statistical evaluation and cohort-based outlier mapping for precision transcriptomics.

Extreme bronchiolitis sufferers had signatures linked to the immune system, interferon signaling, and cytokine signaling, with marked intercourse variations in XIST, RPS4Y1, KDM5D, and LINC00278 for severity. A number of sufferers had distinctive secondary infections, cytokine activation, immune responses, organic pathways, and immune cell activation, highlighting the necessity for outlining patient-level transcriptomic signatures. Balancing relative contributions of cohort-based biomarker discoveries with affected person’s organic responses is required to grasp totality of mechanisms of hostile outcomes in viral bronchiolitis.

Recombinant Virus VEGF E (Orf Virus) Protein, His, E.coli-2ug

QP10912-2ug 2ug
EUR 186

VEGF-E Vascular Endothelial Growth Factor-E Recombinant Protein(Orf Virus)

PROTQ2F842 Regular: 10ug
EUR 380.4
Description: A DNA sequence encoding the mature variant of ovVEGF-E isolate D1701 (Dehio et al., 1999; GenBank accession No. AF106020) was expressed in E. coli as a 132 amino acid residue fusion protein with an N-terminal His-tag sequence and a thrombin cleavage site. Recombinant VEGF-E homodimer was dimerized in vitro and has a predicted mass of approximately 35 kDa.

Hepatitis E virus ORF 3 Recombinant Protein

53-335 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 3 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein

53-336 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Hepatitis E virus ORF 2 Recombinant Protein

53-337 0.01 mg
EUR 651.3
Description: Hepatitis E virus ORF 2 Recombinant Protein

Hepatitis E virus ORF 2 recombinant antigen

8942 100 ug
EUR 477.6
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB.

Hepatitis E virus ORF 2 recombinant antigen

8943 100 ug
EUR 477.6
Description: This is Hepatitis E virus ORF 2 recombinant antigen for ELISA,WB.

Hepatitis E virus ORF 3 recombinant antigen

8944 100 ug
EUR 477.6
Description: This is Hepatitis E virus ORF 3 recombinant antigen for ELISA,WB.

Rabbit Polyclonal antibody Anti-CRBN

Anti-CRBN 50 µg
EUR 418.8

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

7-01759 2µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

7-01760 10µg Ask for price

Recombinant Vascular Endothelial Growth Factor-E (Orf Virus)

7-01761 1mg Ask for price

Vascular Endothelial Growth Factor-E (Orf Virus) Protein

20-abx263083
  • EUR 393.60
  • EUR 10382.40
  • EUR 276.00
  • 10 ug
  • 1 mg
  • 2 µg

Anti-Zika Virus Envelope Protein E Antibody

STJ503579 100 µg
EUR 571.2

Hepatitis E Virus protein

30R-AH054X 500 ug
EUR 1383.6
Description: Hepatitis E Virus Mosaic recombinant protein

Hepatitis E Virus protein

30-AH29 1 mg
EUR 1196.4
Description: Hepatitis E Virus recombinant protein

Hepatitis E Virus antibody

70R-HR003 100 ug
EUR 418.8
Description: Affinity purified Rabbit polyclonal Hepatitis E Virus antibody

Deoxybrevianamide E

D083-1MG 1 mg
EUR 333.6

Deoxybrevianamide E

D083-5MG 5 mg
EUR 1076.4

Cytochalasin E

C197-1MG 1 mg
EUR 157.2

Cytochalasin E

C197-5MG 5 mg
EUR 462

Paraherquamide E

P070-0.5MG 0.5 mg
EUR 480

Paraherquamide E

P070-2.5MG 2.5 mg
EUR 1590

Phenelfamycin E

P078-1MG 1 mg
EUR 381.6

Phenelfamycin E

P078-5MG 5 mg
EUR 1248

Oligomycin E

O021-1MG 1 mg
EUR 381.6

Oligomycin E

O021-5MG 5 mg
EUR 1248

Roquefortine E

R035-1MG 1 mg
EUR 268.8

Roquefortine E

R035-5MG 5 mg
EUR 849.6

Anti-Zika Virus Envelope (E) Protein monoclonal Antibody

CABT-B8528 1 mg
EUR 1064.4

Anti-Zika Virus Envelope Protein E Antibody BIOTIN

STJ503580 100 µg
EUR 703.2

Anti-Zika Virus Envelope Protein E Antibody FITC

STJ503581 100 µg
EUR 703.2

Hepatitis E Virus protein (HRP)

65-IH35 1 ml
EUR 1326
Description: Purified recombinant Hepatitis E Virus protein (HRP)

Recombinant Hepatitis E Virus ORF3 

7-07450 100µg Ask for price

Recombinant Hepatitis E Virus ORF3 

7-07451 500µg Ask for price

Recombinant Hepatitis E Virus ORF3 

7-07452 1000µg Ask for price

Hepatitis E Virus ORF3 Protein

20-abx260138
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Hepatitis E virus PCR kit

PCR-H498-48R 50T
EUR 987.6

Hepatitis E virus PCR kit

PCR-H498-96R 100T
EUR 1335.6

Recombinant Zika Virus E Protein

VAng-Lsx0581-100g 100 µg
EUR 1365.6
Description: Zika Virus Envelope, recombinant protein from Insect cells.

Anti-VEGF antibody

PAab09391 100 ug
EUR 463.2

anti- VEGF antibody

FNab09391 100µg
EUR 658.5
Description: Antibody raised against VEGF

Anti- VEGF antibody

FNab09933 100µg
EUR 658.5
Description: Antibody raised against VEGF

Anti-VEGF antibody

STJ97787 200 µl
EUR 236.4
Description: Rabbit polyclonal to VEGF.

Anti-VEGF antibody

STJ119887 100 µl
EUR 471.6
Description: This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site.

Human vascular endothelial cell growth factor E, VEGF-E ELISA Kit

CSB-E15022h-24T 1 plate of 24 wells
EUR 198
Description: Quantitativesandwich ELISA kit for measuring Human vascular endothelial cell growth factor E, VEGF-E in samples from serum, urine, cell culture supernates, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human vascular endothelial cell growth factor E, VEGF-E ELISA Kit

1-CSB-E15022h
  • EUR 813.60
  • EUR 5572.80
  • EUR 2960.40
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Quantitativesandwich ELISA kit for measuring Human vascular endothelial cell growth factor E, VEGF-E in samples from serum, urine, cell culture supernates, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Mouse anti- hepatitis E virus IgM antibody ELISA Kit

ELA-E1791m 96 Tests
EUR 1038

Polyclonal Goat anti-GST α-form

GST-ANTI-1 50 uL
EUR 336

Polyclonal Goat anti-GST μ-form

GST-ANTI-2 50 uL
EUR 336

Polyclonal Goat anti-GST p-form

GST-ANTI-3 50 uL
EUR 336

Azithromycin impurity E EvoPure®

A074-5MG 5 mg
EUR 835.2

Recombinant Hepatitis B Virus e-Antigen

7-07423 5µg Ask for price

Recombinant Hepatitis B Virus e-Antigen

7-07424 25µg Ask for price

Recombinant Hepatitis B Virus e-Antigen

7-07425 1000µg Ask for price

Hepatitis B Virus E Antigen Antibody

20-abx134030
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody

20-abx134031
  • EUR 427.20
  • EUR 644.40
  • EUR 260.40
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus e-Antigen Protein

20-abx260781
  • EUR 4101.60
  • EUR 393.60
  • EUR 276.00
  • 1 mg
  • 25 ug
  • 5 ug

Dengue virus 1 E recombinant antigen

8812 100 ug
EUR 477.6
Description: This is Dengue virus 1 E recombinant antigen for ELISA,WB.

Dengue virus 2 E recombinant antigen

8813 100 ug
EUR 477.6
Description: This is Dengue virus 2 E recombinant antigen for ELISA,WB.

Dengue virus 3 E recombinant antigen

8814 100 ug
EUR 477.6
Description: This is Dengue virus 3 E recombinant antigen for ELISA,WB.

Dengue virus 4 E recombinant antigen

8815 100 ug
EUR 477.6
Description: This is Dengue virus 4 E recombinant antigen for ELISA,WB.

Hepatitis E virus (ratHEV) PCR kit

PCR-V372-48R 50T
EUR 987.6

Hepatitis E virus (ratHEV) PCR kit

PCR-V372-96R 100T
EUR 1335.6

Hepatitis E virus RT PCR kit

RTq-H498-100R 100T
EUR 1573.2

Hepatitis E virus RT PCR kit

RTq-H498-150R 150T
EUR 2144.4

Hepatitis E virus RT PCR kit

RTq-H498-50R 50T
EUR 1155.6

QPCR Kit RNA Hepatitis E virus

MOL6646 EACH
EUR 839.04

Swine HEPATITIS E virus Antibodies IgM

QY-E40197 96T
EUR 480

Swine HEPATITIS E virus Antibodies IgG

QY-E40198 96T
EUR 480

Anti-VEGF Antibody Clone VEGF/1063, Unconjugated-100ug

7422-MSM1-P1 100ug
EUR 513.6

Anti-VEGF-C Antibody

A00623 100ul
EUR 476.4
Description: Rabbit Polyclonal Antibody for VEGF-C Antibody (VEGFC) detection.tested for IHC, WB in Human, Mouse, Rat.

Anti-VEGF/Vegfa Antibody

A00045 100ug/vial
EUR 352.8

Anti-VEGF/VEGF164 Antibody

A00045-1 100ug/vial
EUR 352.8

Anti-VEGF/Vegfa Antibody

A00045-2 100ug/vial
EUR 352.8

Anti-VEGF/VEGFA Antibody

PA1080 100ug/vial
EUR 400.8

Anti-VEGF/VEGFA Antibody

PB9071 100ug/vial
EUR 400.8

Anti-VEGF-C antibody

STJ96662 200 µl
EUR 236.4
Description: Rabbit polyclonal to VEGF-C.

Anti-VEGF-B antibody

STJ96851 200 µl
EUR 236.4
Description: Rabbit polyclonal to VEGF-B.

anti-VEGF Receptor 3

YF-PA23727 50 ul
EUR 400.8
Description: Mouse polyclonal to VEGF Receptor 3

anti-VEGF Receptor 1

YF-PA11817 50 ug
EUR 435.6
Description: Mouse polyclonal to VEGF Receptor 1

anti-VEGF Receptor 1

YF-PA11818 100 ug
EUR 483.6
Description: Rabbit polyclonal to VEGF Receptor 1

Mouse Anti-Hepatitis B Virus E Antibody (HBeAb) ELISA Kit

abx053819-96tests 96 tests
EUR 801.6

Human anti-hepatitis B virus e antibody,HBeAb ELISA Kit

201-12-1603 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human anti-hepatitis B virus e antibody, HBeAb ELISA Kit

CSB-E09570h-24T 1 plate of 24 wells
EUR 198
Description: Qualitative competitive ELISA kit for measuring Human anti-hepatitis B virus e antibody, HBeAb in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human anti-hepatitis B virus e antibody, HBeAb ELISA Kit

1-CSB-E09570h
  • EUR 667.20
  • EUR 4634.40
  • EUR 2472.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Qualitative competitive ELISA kit for measuring Human anti-hepatitis B virus e antibody, HBeAb in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human anti-hepatitis B virus e antibody(HBeAb)ELISA Kit

GA-E1619HM-48T 48T
EUR 346.8

Human anti-hepatitis B virus e antibody(HBeAb)ELISA Kit

GA-E1619HM-96T 96T
EUR 559.2

Human anti-hepatitis B virus e antibody(HBeAb)ELISA Kit

QY-E02515 96T
EUR 433.2

CLIA kit for Human E-Cad (E-Cadherin)

E-CL-H0014 1 plate of 96 wells
EUR 700.8
Description: A sandwich CLIA kit for quantitative measurement of Human E-Cad (E-Cadherin) in samples from Serum, Plasma, Cell supernatant

CLIA kit for Mouse APO-E (Apolipoprotein E)

E-CL-M0101 1 plate of 96 wells
EUR 700.8
Description: A sandwich CLIA kit for quantitative measurement of Mouse APO-E (Apolipoprotein E) in samples from Serum, Plasma, Cell supernatant

CLIA kit for Mouse E-Cad (E-Cadherin)

E-CL-M0154 1 plate of 96 wells
EUR 700.8
Description: A sandwich CLIA kit for quantitative measurement of Mouse E-Cad (E-Cadherin) in samples from Serum, Plasma, Cell supernatant

CLIA kit for Rat E-Cad (E-Cadherin)

E-CL-R0226 1 plate of 96 wells
EUR 700.8
Description: A sandwich CLIA kit for quantitative measurement of Rat E-Cad (E-Cadherin) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Human E-Cad (E-Cadherin)

E-EL-H0014 1 plate of 96 wells
EUR 452.4
Description: A sandwich ELISA kit for quantitative measurement of Human E-Cad (E-Cadherin) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Mouse E-Cad (E-Cadherin)

E-EL-M0211 1 plate of 96 wells
EUR 452.4
Description: A sandwich ELISA kit for quantitative measurement of Mouse E-Cad (E-Cadherin) in samples from Serum, Plasma, Cell supernatant

ELISA kit for Rat E-Cad (E-Cadherin)

E-EL-R0347 1 plate of 96 wells
EUR 452.4
Description: A sandwich ELISA kit for quantitative measurement of Rat E-Cad (E-Cadherin) in samples from Serum, Plasma, Cell supernatant

Nitrogen-Phosphorus Pesticides Mix E

5252-E 1ML
EUR 476.52

VEGFE protein (Orf virus)

30R-AV011 5 ug
EUR 537.6
Description: Purified recombinant VEGFE protein (Orf virus)

Dengue virus 1 E antigen Recombinant Protein

53-307 0.01 mg
EUR 651.3
Description: Dengue virus 1 E antigen Recombinant Protein

Dengue virus 2 E antigen Recombinant Protein

53-308 0.01 mg
EUR 651.3
Description: Dengue virus 2 E antigen Recombinant Protein

Dengue virus 3 E antigen Recombinant Protein

53-309 0.01 mg
EUR 651.3
Description: Dengue virus 3 E antigen Recombinant Protein

Dengue virus 4 E antigen Recombinant Protein

53-310 0.01 mg
EUR 651.3
Description: Dengue virus 4 E antigen Recombinant Protein

Hepatitis B virus E antigen Recombinant Protein

53-314 0.01 mg
EUR 852.9
Description: Hepatitis B virus E antigen Recombinant Protein

Recombinant Hepatitis E Virus ORF2  (633-659)

7-07441 100µg Ask for price

Recombinant Hepatitis E Virus ORF2  (633-659)

7-07442 500µg Ask for price

Recombinant Hepatitis E Virus ORF2  (633-659)

7-07443 1000µg Ask for price

Recombinant Hepatitis E Virus ORF2  (403-461)

7-07444 100µg Ask for price

Recombinant Hepatitis E Virus ORF2  (403-461)

7-07445 500µg Ask for price

Recombinant Hepatitis E Virus ORF2  (403-461)

7-07446 1000µg Ask for price

Recombinant Hepatitis E Virus ORF2  (452-617)

7-07447 100µg Ask for price

Recombinant Hepatitis E Virus ORF2  (452-617)

7-07448 500µg Ask for price

Recombinant Hepatitis E Virus ORF2  (452-617)

7-07449 1000µg Ask for price

Hepatitis B Virus E Antigen Antibody (HRP)

20-abx134032
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (HRP)

20-abx134033
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (FITC)

20-abx134034
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (FITC)

20-abx134035
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (Biotin)

20-abx134036
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen Antibody (Biotin)

20-abx134037
  • EUR 460.80
  • EUR 727.20
  • EUR 276.00
  • 100 ul
  • 200 ul
  • 30 ul

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021771-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021772-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021773-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021774-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021775-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021798-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021799-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021800-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021801-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021802-1mg 1 mg
EUR 1178.4

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021803-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021804-1mg 1 mg
EUR 886.8

Hepatitis B Virus E Antigen (HBeAg) Antibody

abx021805-1mg 1 mg
EUR 886.8

Hepatitis E Virus ORF2 (452-617) Protein

20-abx260268
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Hepatitis E Virus ORF2 (633-659) Protein

20-abx260269
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

Hepatitis E Virus ORF2 (403-461) Protein

20-abx260270
  • EUR 1062.00
  • EUR 410.40
  • EUR 1930.80
  • 0.5 mg
  • 100 ug
  • 1 mg

West Nile Virus E protein (His tag)

80-1339 100 ug
EUR 289.2
Description: Purified recombinant West Nile Virus E protein (His tag)

Hepatitis B virus e ag recombinant antigen

8915 100 ug
EUR 673.36
Description: This is Hepatitis B virus e ag recombinant antigen for ELISA,WB.

Varicella-zoster virus Envelope glycoprotein E (gE)

1-CSB-CF362630VAP
  • EUR 1738.80
  • EUR 867.60
  • EUR 1173.60
  • 1MG
  • 200ug
  • 500ug
Description: Recombinant Varicella-zoster virus Envelope glycoprotein E(gE) expressed in in vitro E.coli expression system

Hepatitis E virus One-Step PCR kit

Oneq-H498-100R 100T
EUR 1932

Hepatitis E virus One-Step PCR kit

Oneq-H498-150R 150T
EUR 2646

Hepatitis E virus One-Step PCR kit

Oneq-H498-50R 50T
EUR 1410

Hepatitis E virus (ratHEV) RT PCR kit

RTq-V372-100R 100T
EUR 1573.2

Hepatitis E virus (ratHEV) RT PCR kit

RTq-V372-150R 150T
EUR 2144.4

Respiratory Syncytial Virus (RSV) is the foremost explanation for decrease respiratory tract an infection in infants, in whom, the sensing of RSV by innate immune receptors and its regulation are nonetheless poorly described. Nevertheless, the extreme bronchiolitis following RSV an infection in neonates has been related to a defect in sort I interferons (IFN-I) manufacturing, a cytokine produced primarily by alveolar macrophages (AMs) upon RSV an infection in adults. Within the current research, neonatal C57BL/6 AMs mobilized very weakly the IFN-I pathway upon RSV an infection in vitro and did not restrain virus replication.

Leave a Reply

Your email address will not be published. Required fields are marked *